BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |